EIN Clinical Trials in Toronto, Ontario
16 recruitingToronto, Ontario, Canada
Showing 1–16 of 16 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled179 locationsNCT05457283
Recruiting
Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche152 enrolled82 locationsNCT05271409
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled164 locationsNCT05196035
Recruiting
Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
IgA VasculitisHenoch-Schönlein PurpuraPrimary Cutaneous Vasculitis+1 more
University of Pennsylvania90 enrolled16 locationsNCT02939573
Recruiting
VCRC Tissue Repository
Microscopic PolyangiitisGiant Cell ArteritisTakayasu Arteritis+8 more
University of Pennsylvania1,000 enrolled8 locationsNCT02967068
Recruiting
Not Applicable
Building Blocks for Child and Family Well-being
Parenting skillsFamily Well-beingFamily Cohesion
York University32 enrolled2 locationsNCT07351630
Recruiting
Not Applicable
Validating IAAO for Muscle Outcomes
Protein metabolism
University of Toronto8 enrolled1 locationNCT07317921
Recruiting
Not Applicable
Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise
Protein metabolismMenstrual CycleFemale Sex Hormones+1 more
University of Toronto20 enrolled1 locationNCT07258576
Recruiting
Not Applicable
Animal and Microbial-based Dietary Protein Efficiency in Adults
Protein metabolism
Daniel Moore13 enrolled1 locationNCT07148908
Recruiting
Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women
Well-Being, Psychological
Samuel Lunenfeld Research Institute, Mount Sinai Hospital200 enrolled1 locationNCT06002763
Recruiting
Phase 1Phase 2
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Advanced Solid TumorsCarcinomaNeoplasms+9 more
Marengo Therapeutics, Inc.365 enrolled32 locationsNCT05592626
Recruiting
Not Applicable
M3-JIA: Making Mindfulness Matter for Children With JIA
Mental HealthChildrenJuvenile Idiopathic Arthritis+1 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's74 enrolled3 locationsNCT06376149
Recruiting
Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry
Ebstein AnomalyTricuspid Valve Dysplasia
The Hospital for Sick Children1,500 enrolled1 locationNCT05225311
Recruiting
Not Applicable
Intensive Care Unit Resident Scheduling Trial
Patient SafetyWell-beingEducation
The Hospital for Sick Children20 enrolled5 locationsNCT04176094